Aavkar Drugs Profile
Key Indicators
- Authorised Capital ₹ 2.50 Cr
- Paid Up Capital ₹ 2.02 Cr
- Company Age 8 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 5.00 Cr
- Satisfied Charges ₹ 13.16 Cr
- Revenue Growth -15.70%
- Profit Growth 11.13%
- Ebitda -5.20%
- Net Worth 23.91%
- Total Assets -1.77%
About Aavkar Drugs
Aavkar Drugs Private Limited (ADPL) is a Private Limited Indian Non-Government Company incorporated in India on 23 September 2016 (Eight years and four months 9 days old ). Its registered office is in Vadodara, Gujarat, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 Cr and a paid-up capital of Rs 2.02 Cr.
The company currently has active open charges totaling ₹5.00 Cr. The company has closed loans amounting to ₹13.16 Cr, as per Ministry of Corporate Affairs (MCA) records.
Brijesh Kothia, Vijay Bhesania, and Ashwin Ramani serve as directors at the Company.
Company Details
- Location
Vadodara, Gujarat, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U24298GJ2016PTC093862
- Company No.
093862
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Sep 2016
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Aavkar Drugs?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Brijesh Kothia  | Director | 23-Sep-2016 | Current |
| Vijay Bhesania | Director | 23-Sep-2016 | Current |
| Ashwin Ramani | Director | 23-Sep-2016 | Current |
Financial Performance of Aavkar Drugs.
Aavkar Drugs Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 15.7% decrease. The company also saw a substantial improvement in profitability, with a 11.13% increase in profit. The company's net worth Soared by an impressive increase of 23.91%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Aavkar Drugs?
In 2023, Aavkar Drugs had a promoter holding of 24.21% and a public holding of 75.79%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Brk Life Science LlpBrijesh Kothia, Vijay Bhesania and 1 more are mutual person
Charges (Loans)
₹5.00 Cr
₹13.16 Cr
Charges Breakdown by Lending Institutions
- Others : 5.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 31 Jan 2023 | Others | ₹5.00 Cr | Open |
| 03 Jul 2017 | Others | ₹6.58 Cr | Satisfied |
| 31 Mar 2017 | Others | ₹6.58 Cr | Satisfied |
How Many Employees Work at Aavkar Drugs?
Aavkar Drugs has a workforce of 14 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aavkar Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aavkar Drugs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
